semaglutide and rectal bleeding Bloody Stool on Semaglutide: What to Know Constipation & Weight Loss Medications

SELECT was the first trial to demonstrate cardiovascular event reduction with a GLP-1 receptor agonist in people with obesity but without diabetes, and supported the expansion of Wegovy's FDA indication to include cardiovascular risk reduction

Lillys Zepbound, approved in November 2023 as the Indiana-based drug giants answer to Novo Nordisks Wegovy, showed 21% average weight loss after 72 weeks for its highest dose in its Phase 3 trial, and a mid-stage study of another Lilly experimental medicine, called retatrutide, showed 24% weight loss after just 48 weeks

[DOI] [PubMed] [Google Scholar] 23.Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease

Skin appears more rested and luminous

For female patients, HCG is commonly used in fertility treatments, but when used alongside testosterone therapy, it may help in cases where hormonal balance needs to be maintained